Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Organon & Co. (OGN : NYSE)

• Company Description    Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J. Number of Employees: 10,000

• Price / Volume Information    Yesterday's Closing Price: $13.63 Daily Weekly Monthly 20 Day Moving Average: 3,155,212 shares Shares Outstanding: 262.61 (millions) Market Capitalization: $3,579.37 (millions) Beta: 1.52 52 Week High: $13.79 52 Week Low: $5.69 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.66% 2.06% 12 Week 1.49% 0.27% Year To Date 90.10% 71.41%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 30 Hudson Street FL 33 - Jersey City,NJ 07302 USA ph: 551-430-6900 fax: - investor_relations@organon.com http://www.organon.com

• General Corporate Information    Officers Joseph Morrissey - Interim Chief Executive Officer Carrie Cox - Executive Chair of the Board Matthew Walsh - Chief Financial Officer Lynette Holzbaur - Senior Vice President Finance - Corporate Controll Alan Ezekowitz - Director Peer Information Organon & Co. (CHCR) Organon & Co. (ESRX) Organon & Co. (MYDP) Organon & Co. (COR) Organon & Co. (GBCS) Organon & Co. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 68622V106 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/09/26 Share - Related Items Shares Outstanding: 262.61 Most Recent Split Date: (:1) Beta: 1.52 Market Capitalization: $3,579.37 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.59% Current Fiscal Quarter EPS Consensus Estimate: $0.95 Indicated Annual Dividend: $0.08 Current Fiscal Year EPS Consensus Estimate: $3.22 Payout Ratio: 0.03 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: -0.16 Estmated Long-Term EPS Growth Rate: 3.35% Last Dividend Paid: 08/14/2026 - $0.02 Next EPS Report Date: 11/09/26

• Fundamental Ratios P/E Current FY Estimate: 4.23 Trailing 12 Months: 4.54 PEG Ratio: 1.26 Price Ratios Price/Book: 3.56 Price/Cash Flow: 2.35 Price / Sales: 0.58 EPS Growth vs. Year Ago Period: -14.89% vs. Previous Quarter: 21.21% Sales Growth vs. Year Ago Period: -2.26% vs. Previous Quarter: 6.71% ROE 06/30/26 - 88.97 03/31/26 - 99.95 12/31/25 - 122.01 ROA 06/30/26 - 6.03 03/31/26 - 6.22 12/31/25 - 6.74 Current Ratio 06/30/26 - 1.95 03/31/26 - 1.97 12/31/25 - 1.82 Quick Ratio 06/30/26 - 1.44 03/31/26 - 1.42 12/31/25 - 1.23 Operating Margin 06/30/26 - 12.95 03/31/26 - 13.35 12/31/25 - 14.39 Net Margin 06/30/26 - 3.41 03/31/26 - 3.99 12/31/25 - 3.01 Pre-Tax Margin 06/30/26 - 8.01 03/31/26 - 8.71 12/31/25 - 6.84 Book Value 06/30/26 - 3.83 03/31/26 - 3.44 12/31/25 - 2.89 Inventory Turnover 06/30/26 - 2.06 03/31/26 - 2.03 12/31/25 - 2.03 Debt-to-Equity 06/30/26 - 8.43 03/31/26 - 9.47 12/31/25 - 11.47 Debt-to-Capital 06/30/26 - 89.39 03/31/26 - 90.45 12/31/25 - 91.98

Powered by Zacks Investment Research ©